Miklós Lengyel

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Venues

British journal of pharmacology

Molecular pharmacology

PloS one

International journal of molecular sciences

Semmelweis Egyetem

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Semmelweis Egyetem

Hungary

PhD Student :: Department of Physiology

Semmelweis Egyetem

Hungary

Undergraduate research student :: Department of Physiology

Publications

Réka Csáki, Chandran Nagaraj, János Almássy, Mohammad Ali Khozeimeh, Dusan Jeremic, Horst Olschewski, Alice Dobolyi, Konrad Hoetzenecker, Andrea Olschewski, Péter Enyedi, Miklós Lengyel
The TREK-1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension. British journal of pharmacology (2024)
Réka Csáki, Chandran Nagaraj, János Almássy, Mohammad Ali Khozeimeh, Dusan Jeremic, Horst Olschewski, Alice Dobolyi, Konrad Hoetzenecker, Andrea Olschewski, Péter Enyedi, Miklós Lengyel
The TREK-1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension. British journal of pharmacology (2024)
Réka Csáki, Chandran Nagaraj, János Almássy, Mohammad Ali Khozeimeh, Dusan Jeremic, Horst Olschewski, Alice Dobolyi, Konrad Hoetzenecker, Andrea Olschewski, Péter Enyedi, Miklós Lengyel
The TREK-1 potassium channel is a potential pharmacological target for vasorelaxation in pulmonary hypertension. British journal of pharmacology 181 (19) (2024)
Zhouyang Shen, Miklós Lengyel, Philipp Niethammer
The yellow brick road to nuclear membrane mechanotransduction. APL bioengineering 6 (2) (2022)
Miklós Lengyel, Péter Enyedi, Gábor Á Czirják
Negative Influence by the Force: Mechanically Induced Hyperpolarization via K2P Background Potassium Channels. International journal of molecular sciences 22 (16) (2021)
Davor Skofic Maurer, Diana Zabini, Chandran Nagaraj, Neha Sharma, Miklós Lengyel, Bence Miklos Nagy, Saša Frank, Walter Klepetko, Elisabeth Gschwandtner, Péter Enyedi, Grazyna Kwapiszewska, Horst Olschewski, Andrea Olschewski
Endothelial Dysfunction Following Enhanced TMEM16A Activity in Human Pulmonary Arteries. Cells 9 (9) (2020)
Miklós Lengyel, Ferenc Erdélyi, Enikő Pergel, Ágnes Bálint-Polonka, Alice Dobolyi, Péter Bozsaki, Mária Dux, Kornél Király, Tamás Hegedűs, Gábor Á Czirják, Péter Mátyus, Péter Enyedi
Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K2P18.1) Background Potassium Channel. Molecular pharmacology 95 (6) (2019)
Enikő Pergel, Miklós Lengyel, Péter Enyedi, Gábor Á Czirják
TRESK (K2P18.1) Background Potassium Channel Is Activated by Novel-Type Protein Kinase C via Dephosphorylation. Molecular pharmacology 95 (6) (2019)
Miklós Lengyel, Gábor Á Czirják, Péter Enyedi
TRESK background potassium channel is not gated at the helix bundle crossing near the cytoplasmic end of the pore. PloS one 13 (5) (2018)
Miklós Lengyel, Alice Dobolyi, Gábor Á Czirják, Péter Enyedi
Selective and state-dependent activation of TRESK (K2P 18.1) background potassium channel by cloxyquin. British journal of pharmacology 174 (13) (2017)

Miklós Lengyel.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Miklós Lengyel